Preview

Pacific Medical Journal

Advanced search

Pulmonary function test in patients with asthma and chronic obstructive pulmonary disease in conditions of impared carbohydrate metabolism

https://doi.org/10.34215/1609-1175-2022-2-38-43

Abstract

Objective: To study the state of pulmonary function tests (PFTs) in patients having non-allergic variant of bronchial asthma (NABA) and chronic obstructive pulmonary disease (COPD) either particularly or in combination with diabetes mellitus type 2 (DM2) in the context of the effect of glycemic control on PFTs.
Methods: Such groups of patients as patients having NABA (n=61), patients suffering NABA combined with DM2 (n=20), patients with COPD (n=55); and patients having diagnosed COPD combined with DM2 (n=12) were examined. The blood glucose level was determined by the hexokinase method, the level of glycated hemoglobin was measured using the immunoinhibition method. PFTs were evaluated using spirometry, bronchodilator test, and body plethysmography (MasterScreen SN5112116, CareFusion 234 GmbH).
Results: Statistically significant decrease of VС, FVC, and an increase of Raw in the group of patients with a combination of NABA and DM2 compared with the group having NABA was observed. An increase of Raw in the group with a combination of COPD and DM2 in comparison with the group having COPD was observed. Moreover negative correlations between the parameters of PFTs in different groups and the degree of carbohydrate metabolism disorders were detected.
Conclusions: PFT indexes of patients having obstructive pulmonary pathology on the background of carbohydrate metabolism disorder tend to decrease due to different factors, especially glication of proteins.

About the Authors

A. S. Pavlova
Academician I.P. Pavlov First St. Petersburg State Medical University
Russian Federation

Anastasiia S.Pavlova, MD, postgraduate student Hospital Therapy Department

6–8, Lva Tolstogo St., Saint Petersburg, 197022



L. N. Sorokina
Academician I.P. Pavlov First St. Petersburg State Medical University
Russian Federation

Lada N.Sorokina, MD, PhD, prof. Hospital Therapy Department

6–8, Lva Tolstogo St., Saint Petersburg, 197022



V. N. Mineev
Academician I.P. Pavlov First St. Petersburg State Medical University
Russian Federation

Valery N.Mineev, MD, PhD, prof. Hospital Therapy Department

6–8, Lva Tolstogo St., Saint Petersburg, 197022

+7 921 359 62 95



M. A. Nyoma
Academician I.P. Pavlov First St. Petersburg State Medical University
Russian Federation

Mikhail A.Nyoma, MD, PhD, docent, Hospital Therapy Department

6–8, Lva Tolstogo St., Saint Petersburg, 197022



V. I. Trofimov
Academician I.P. Pavlov First St. Petersburg State Medical University
Russian Federation

Vasiliy I.Trofimov, MD, PhD, Head of Hospital Therapy Department

6–8, Lva Tolstogo St., Saint Petersburg, 197022



References

1. Song Y, Klevak A, Manson JE, Buring JE, Liu S. Asthma, сhronic obstructive pulmonary disease, and type 2 diabetes in the women’s health study. Diabetes Res Clin Pract. 2010;90(3):365–371. doi:10.1016/j.diabres.2010.09.010.

2. Ehrlich SF, Quesenberry JrCP, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010;33(1):55–60. doi: 10.2337/dc09-0880.

3. Russian Respiratory Society. Clinical recommendations. Chronic obstructive pulmonary disease. Moscow; 2018 (in Russ.). URL:https://spulmo.ru/download/asthma2018.pdf (Accessed Jun 19, 2021).

4. Russian Respiratory Society. Clinical recommendations. Chronic obstructive pulmonary disease. Moscow; 2018 (in Russ.)]. URL:https://spulmo.ru/upload/federal_klinicheskie_rekomendaciy_hobl.pdf (Accessed Jun 19, 2021).

5. II Dedov, MV Shestakova, AYu Mayorov, editors. Standards of specialized diabetes care. 9th Edition (revised). Moscow, 2019 (in Russ.)]. doi: 10.14341/DM221S1.

6. Galstyan GR, Shestakova EA, Sklyanik IA. Obesity and type 2 diabetes: can we find a compromised treatment solution? Diabetes mellitus. 2017;20(4):270-278 (in Russ.). doi: 10.14341/DM8726.

7. Cavaille`s A., Brinchault-Rabin G., Dixmier A., Goupil F., Gut-Gobert C., Marchand-Adam S., Meurice J., More H., Person Tacnet C., Leroyer C., Diot P. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475. DOI: 10.1183/09059180.00008612.

8. Pitocco D, Fuso L, Conte EG, Zaccardi F, Condoluci C, Scavone G, Incalzi R A, Ghirlanda G. The diabetic lung – a new target organ? The review of diabetic studies. 2012;9(1), 23–35. doi:10.1900/RDS.2012.9.23.

9. Hsia CCW, Raskin P. Lung involvement in diabetes. Does it matter? Diabetes Care. 2008;31(4):828-829. doi: 10.2337/dc08-0103.

10. Uz-Zaman S, Banerjee J, Singhamahapatra A, Kumar Dey P, Roy A, Roy K, Roy K.(Basu). Assessment of lung function by spirometry and diffusion study and effect of glycemic control on pulmonary function in type 2 diabetes mellitus patients of the Eastern India. Journal of Clinical and Diagnostic Research. 2014;8(11):01-04. doi:10.7860/JCDR/2014/9756.5076.

11. Ivanov VA, Sorokina LN, Mineev VN, Shestakova NE, Bystrova AA, Trofimov VI. Comorbidity of asthma and diabetes: synergism or antagonism? Pulmonologiya. 2014;(6):103-107 (in Russ.). https://doi.org/10.18093/0869-0189-2014-0-6-103-107.

12. Sorokina LN, Ivanov VA, Lim VV, Mineev VN, Trofimov VI. Cytokine profile features in the patients with non-allergic bronchial asthma with co-existing type 2 diabetes mellitus. Medical Immunology. 2017;19(3):313- 318 (in Russ.) doi: 10.15789/1563-0625-2017-3-313-318.

13. Mueller NT, Koh W, Odegaard AO, Gross MD, Yuan J, Pereira MA. Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study. Diabetes Res Clin Pract. 2013;99(2):192–199. doi:10.1016/j.diabres.2012.11.019.

14. Dekkers BGJ, Schaafsma D, Tran T, Zaagsma J, Meurs H. Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. Am J Respir Cell Mol Biol. 2009;41:494–504. doi: 10.1165/rcmb.2008-0251OC.

15. Bakker H, Jaddoe VWV. Cardiovascular and metabolic influences of fetal smoke exposure. Eur J Epidemiol. 2011;26:763–770. doi: 10.1007/s10654-011-9621-2.


Review

For citations:


Pavlova A.S., Sorokina L.N., Mineev V.N., Nyoma M.A., Trofimov V.I. Pulmonary function test in patients with asthma and chronic obstructive pulmonary disease in conditions of impared carbohydrate metabolism. Pacific Medical Journal. 2022;(2):38-43. (In Russ.) https://doi.org/10.34215/1609-1175-2022-2-38-43

Views: 203


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1609-1175 (Print)